London Regional Cancer Program, London Health Sciences Centre, Department of Anatomy & Cell Biology, Western University, London, ON N6A 5W9, Canada.
London Regional Cancer Program, London Health Sciences Centre, Departments of Anatomy & Cell Biology and Oncology, Western University, London, ON N6A 5W9, Canada.
Int J Mol Sci. 2019 May 8;20(9):2272. doi: 10.3390/ijms20092272.
Breast cancer is the most commonly diagnosed cancer in women worldwide, and >90% of breast cancer-related deaths are associated with metastasis. Breast cancer spreads preferentially to the lung, brain, bone and liver; termed organ tropism. Current treatment methods for metastatic breast cancer have been ineffective, compounded by the lack of early prognostic/predictive methods to determine which organs are most susceptible to developing metastases. A better understanding of the mechanisms that drive breast cancer metastasis is crucial for identifying novel biomarkers and therapeutic targets. Lung metastasis is of particular concern as it is associated with significant patient morbidity and a mortality rate of 60-70%. This review highlights the current understanding of breast cancer metastasis to the lung, including discussion of potential new treatment approaches for development.
乳腺癌是全球女性最常见的癌症,超过 90%的乳腺癌相关死亡与转移有关。乳腺癌优先转移到肺、脑、骨和肝,称为器官嗜性。目前转移性乳腺癌的治疗方法效果不佳,加之缺乏早期预后/预测方法来确定哪些器官最容易发生转移,情况更为复杂。深入了解导致乳腺癌转移的机制对于确定新的生物标志物和治疗靶点至关重要。肺转移尤其令人担忧,因为它与患者的高发病率和 60-70%的死亡率有关。本综述强调了目前对乳腺癌肺转移的认识,包括讨论潜在的新治疗方法的开发。